Nom du produit:1-Bromo-4-chloroimidazo[1,2-a]quinoxaline
IUPAC Name:1-bromo-4-chloroimidazo[1,2-a]quinoxaline
- CAS:1254196-52-5
- Formule moléculaire:C10H5BrClN3
- Pureté:95%
- Numéro de catalogue:CM221304
- Poids moléculaire:282.53
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1254196-52-5
- Formule moléculaire:C10H5BrClN3
- Point de fusion:-
- Code SMILES:ClC1=NC2=C(N3C1=NC=C3Br)C=CC=C2
- Densité:
- Numéro de catalogue:CM221304
- Poids moléculaire:282.53
- Point d'ébullition:
- N° Mdl:MFCD18711463
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
- Imidazopyrazines
- In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.